Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Proteolix
company
About
Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies
- 10001 - max
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $79M
- Industries
- Biopharma,Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 10001 - max
- Operating Status
- Close
Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$79M
Proteolix has raised a total of
$79M
in funding over 2 rounds. Their latest funding was raised on
Sep 8, 2008 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 8, 2008 | Series C | $79M | 1 |
Phase4 Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Proteolix is funded by 1 investors.
Phase4 Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Phase4 Ventures
|
Yes | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
